vimarsana.com

Latest Breaking News On - Lexaria bioscience corp - Page 1 : vimarsana.com

Lexaria Bioscience Corp : Lexaria Awards Contract For Third GLP-1 Human Pilot Study

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company"

Lexaria Awards Contract For Third GLP-1 Human Pilot Study

Lexaria Awards Contract For Third GLP-1 Human Pilot Study
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Lexaria Bioscience Corp : Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy

KELOWNA, BC / ACCESSWIRE / May 21, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces two important new patent

Lexaria Receives Two New Medical-Treatment Patents in Hypertension

Lexaria Receives Two New Medical-Treatment Patents in Hypertension
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy

Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.